International Journal of Advances in Science, Engineering and Technology(IJASEAT)
.
Follow Us On :
current issues
Volume-12,Issue-1  ( Jan, 2024 )
Past issues
  1. Volume-12,Issue-1  ( Jan, 2024 )
  2. Volume-11,Issue-4  ( Oct, 2023 )
  3. Volume-11,Issue-3  ( Jul, 2023 )
  4. Volume-11,Issue-2  ( Apr, 2023 )
  5. Volume-11,Issue-1  ( Jan, 2023 )
  6. Volume-10,Issue-4  ( Oct, 2022 )
  7. Volume-10,Issue-3  ( Jul, 2022 )
  8. Volume-10,Issue-2  ( Apr, 2022 )
  9. Volume-10,Issue-1  ( Jan, 2022 )
  10. Volume-9,Issue-4  ( Oct, 2021 )

Statistics report
Apr
Submitted Papers : 80
Accepted Papers : 10
Rejected Papers : 70
Acc. Perc : 12%
  Journal Paper


Paper Title :
Exploring the Effect of Thymoquinone on Neuropsychological Impairment in Experimentally Induced Fibromyalgia

Author :Anudeep Kaur, Simranpreet Kaur, Rajbir Bhatti

Article Citation :Anudeep Kaur ,Simranpreet Kaur ,Rajbir Bhatti , (2018 ) " Exploring the Effect of Thymoquinone on Neuropsychological Impairment in Experimentally Induced Fibromyalgia " , International Journal of Advances in Science, Engineering and Technology(IJASEAT) , pp. 60-63, Volume-6, Issue-1

Abstract : Abstract - In the present investigation, the effect of thymoquinone on neuropsychological impairment in reserpine induced fibromyalgia has been explored. Fibromyalgia was induced by the administration of 1 mg/kg reserpine to mice for 3 consecutive days. The effect of thymoquinone (10 and 20 mg/Kg) on fibromyalgia was explored. Fibromyalgia was evaluated by using different models such as Eddy’s hot plate test, tail immersion test for evaluating hyperalgesia; forced swim test for depression; inclined plane test for evaluating motor activities and Morris water maze, elevated plus maze test for evaluating acquisition and retention of memory using standard methods. Reserpine administration was found to mimic the effects and symptoms of fibromyalgia. Maximum effect was evident on day 4 and 6 of reserpine treatment as observed by an increase in thermal hyperalgesia, depression, impaired motor- coordination and memory. Pretreatment with the standard drug duloxetine and thymoquinone was found to significantly attenuate reserpine effect in neuropsychological impairment in reserpine induced fibromyalgia from day 2 to 5. However on 5th day of treatment there was 100% mortality in both the treatment groups. The results of study indicate that thymoquinone does not produce any protection in reserpine induced fibromyalgia. Keywords - Fibromyalgia, Pain Reserpine, Thymoquinone

Type : Research paper

Published : Volume-6, Issue-1


DOIONLINE NO - IJASEAT-IRAJ-DOIONLINE-10892   View Here

Copyright: © Institute of Research and Journals

| PDF |
Viewed - 41
| Published on 2018-04-02
   
   
IRAJ Other Journals
IJASEAT updates
Volume-11,Issue-4 (Oct,2023)
The Conference World

JOURNAL SUPPORTED BY